Medidas Mínimas de Bioseguridad en instalaciones de salud durante la Pandemia del SARS-CoV-2
[Minimum Biosafety Measures in healthcare facilities during SARS-CoV-2 Pandemic]

Jorge David Mendez-Rios

Texto completo:

[PDF] Material suplemental

Resumen


Resumen
El SARS-CoV-2 es un nuevo virus, causante de la actual pandemia que nos afecta.  Dada su virulencia y nuestro desconocimiento de su biología, representa una real amenaza para la población. Además de las medidas epidemiológicas, el personal de salud, clínico, técnico y administrativo son el frente para el diagnóstico y tratamiento de nuestra población. Es de suma importancia que nuestro personal pueda implementar medidas básicas para minimizar la exposición y contagio de este virus.  Se ha revisado las recomendaciones generales de la Organización Mundial de Salud para personal de salud sobre requerimientos mínimos que debemos cumplir en tal entorno. También hemos provisto de rótulos que deben ser colocados en toda instalación que maneja muestras de SARS-CoV-2. Es necesario que esta información sea de fácil acceso para todo profesional de salud, y así pueda revisarla e internalizarla para su protección, la de sus pacientes, y familiares. Esperamos que sea de gran utilizad para fortalecer nuestras capacidades de bioseguridad en nuestro país, y utilizar esta información como herramienta educativa y de capacitación básica.

Abstract
SARS-CoV-2 is a new virus, causing the current pandemic affecting us. Given its virulence and our lack of understanding of its biology, it represents a real threat to the population. Additionally to the epidemiological measures, the clinical, technical and administrative personnel are at the front in the battle to diagnose and treat our population. It is of utmost importance that our staff can know and implement basic safety measures to minimize the exposure and spread of this virus. We have reviewed the general recommendations of the World Health Organization for healthcare personnel of the minimum requirements that we must meet in such an environment. Here, it has also been provided banners to be displayed in every facility processing SARS-CoV-2 samples. This guide must be easily accessible for all health professional to be reviewed and internalized for their safety, of their patients, and their families. We hope it will be of great use in our country to strengthen our biosafety capabilities and to use this information for educational and training purposes.


Referencias


Mendez-Rios JD, Martens CA, Bruno DP, Porcella SF, Zheng Z-M, Moss B. Genome Sequence of Erythromelalgia-Related Poxvirus Identifies it as an Ectromelia Virus Strain. Xiang Y, editor. PLoS ONE. 2012 Apr 27;7(4):e34604.

Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clin Microbiol Rev. 2007 Oct 1;20(4):660–94.

WHO. Laboratory biosafety guidance related to thenovel coronavirus (2019-nCoV). 12February2020; Available from: https://www.who.int/docs/default-source/coronaviruse/laboratory-biosafety-novel-coronavirus-version-1-1.pdf

Xiao W, Wang M, Wei W, Wang J, Zhao J, Yi B, et al. [Detection of SARS-CoV and RNA on aerosol samples from SARS-patients admitted to hospital]. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2004 Oct;25(10):882–5.

Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA [Internet]. 2020 Mar 11 [cited 2020 Mar 20]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2762997

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17;NEJMc2004973.

WHO. Laboratory Biosafety Manual. 2004;3rd Ed. Available from: https://www.who.int/csr/resources/publications/biosafety/en/Biosafety7.pdf

Gentilli SM, Potts JM, Clarkson AJ, Jacobi HB. An Overview of the NIH Biorisk Management Program. Appl Biosaf. 2016 Mar;21(1):26–33.

Herman P, Verlinden Y, Breyer D, Van Cleemput E, Brochier B, Sneyers M, et al. Biosafety Risk Assessment of the Severe Acute Respiratory Syndrome (SARS) Coronavirus and Containment Measures for the Diagnostic and Research Laboratories. Appl Biosaf. 2004 Sep;9(3):128–42.

WHO. Coronavirus disease 2019 (COVID-19)Situation Report –66. 2020 Mar 26; Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf

WHO. Water, sanitation, hygiene and waste management for COVID-19. 2020 Mar 3; Available from: https://www.who.int/publications-detail/water-sanitation-hygiene-and-waste-management-for-covid-19

WHO. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during- health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125

Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, et al. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. May RM, McLean AR, Pattison J, Weiss RA, editors. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1091–105.

Ritterson R, Casagrande R. Basic Scholarship in Biosafety Is Critically Needed To Reduce Risk of Laboratory Accidents. Imperiale MJ, editor. mSphere. 2017 Apr 26;2(2):e00010-17, /msph/2/2/e00010-17.atom.




Enlaces refback

  • No hay ningún enlace refback.



 
Revista Oficial de las siguientes instituciones:
 
 
Académia Panameña de Medicina y Cirugía. Derechos reservados 2004-2019. Editorial Médico Infomedic International S,A.